This year, more than ever before, we’ve seen just how important it is for us all to stay connected and work together to build a stronger biotech ecosystem. In the face of great adversity, the biotech community has risen to the challenge and formed new collaborations and partnerships to innovate and rapidly develop new medicines and tools to help us beat this pandemic.
At Maryland Lifesciences’ 2020 Bio Innovation Conference, American Gene Technologies (AGT) took center stage. AGT was the virtual event’s diamond sponsor, AGT’s CEO and Founder Jeff Galvin kicked off the event with opening remarks and then hosted several panel discussions, including “Expanding Progress and Opportunities in Gene and Cell Therapy,” which was a highlight of the conference’s second day.
Dr. Mark DeWitt, a leading industry expert, shares his secrets on success with the development of a CRISPR/Cas9-based strategy
Correction of the Sickle Cell Disease Mutation with CRISPR/Cas9 Description Sickle Cell Disease (SCD), one of the world’s most common genetic disorders, causes anemia and progressive multiorgan damage that typically [….]
Amanda L. Murphy Appointed as Chief Financial Officer to MaxCyte
MaxCyte Appoints Amanda L. Murphy as Chief Financial Officer and Names Ron Holtz as Senior Vice President & Chief Accounting Officer
MaxCyte, Inc., a global cell-based therapies and life sciences company, announced today that Amanda L. Murphy, CFA, has joined the Company as Chief Financial Officer (CFO). Ron Holtz, who has served as MaxCyte’s CFO since 2005, will become Senior Vice President and Chief Accounting Officer (SVP & CAO).
5 Questions with Shruti Abbato, EVP, Business Development, CARMA Cellular Therapies at MaxCyte, Inc.
Shruti has 20 years of business development experience in the biotechnology industry. She is currently responsible for building and growing MaxCyte’s CARMA Cell Therapies business. Before MaxCyte, she worked with Celdara Medical, Millendo, Medigene, Deciphera, and Human Genome Sciences. Shruti holds an MBA from the University of Pittsburgh and a BS in Chemical Engineering and Biochemistry from the University of Maryland.
Top 10 Biotech News Stories from 2019 from the BioHealth Capital Region on biobuzz.io
For 20 Years This Company Has Helped to Shape the Field of Cell Therapy How MaxCyte Has Evolved to Become Leading Technology Provider for Cell Engineering and Leveraged Its Flow [….]
The Story of Maryland’s Cell and Gene Therapy Cluster is Shared Loud and Clear at Inaugural Bio Innovation Conference
The Story of Maryland’s Cell and Gene Therapy Cluster is Shared Loud and Clear at Inaugural Bio Innovation Conference October 8, 2019 On Monday morning in Bethesda, Maryland hundreds of [….]
MaxCyte Adds Vice President, Non-Clinical and Translational Studies, to Support Advancement of Programs from Its CARMA™ Platform
MaxCyte Adds Vice President, Non-Clinical and Translational Studies, to Support Advancement of Programs from Its CARMA™ Platform Dhana Chinnasamy, PhD, will oversee non-clinical and translational activities for MaxCyte’s autologous cell [….]